Disease-free interval after primary treatment predicts prognosis of recurrent endometrial carcinoma.
Ueda Y, Matsumura Y, Egawa-Takata T, Miyake T, Miyatake T, Yoshino K, Fujita M, Matsuzaki S, Yokoyama T, Miyoshi Y, Yamasaki M, Enomoto T, Kimura T.
Ueda Y, et al. Among authors: matsuzaki s.
Anticancer Res. 2010 Oct;30(10):4347-52.
Anticancer Res. 2010.
PMID: 21036762